Revalia Bio, Inc.
New Haven, US · Founded 2021 · Delaware corporation · 37 employees on LinkedIn · 6 known investors
Revalia Bio uses AI to convert donated human organs and tissues into multi-modal biological datasets and decision-ready insights for drug and device development. It operates an Organ ICU facility and works with organ procurement organizations and healthcare institutions to serve pharma, biotech, and medical device companies.
Founders & leadership
GT
Greg TietjeninCo-Founder & Chief Executive Officer
JD
Jenna DiRitoCo-Founder
KS
Kourosh Saeb-ParsyCo-Founder
HH
Helen HughesCo-Founder & Chief People Officer
PB
Peter BuniakCo-Founder & Advisor
JD
Jenna DiRito, PhDinCo-founder · Chief Operating Officer
JN
Janeta NikolovskiChief Data and Innovation Officer
QL
Quentin LashleyVP of IT & Cybersecurity
NB
Nabil BoutagyVP of Human Data Trial Operations
AS
Aniruth SarathyVP of Engineering
Board
MA
BW
Investors · 6
Reported raises · per SEC filings
Form D private placements$12.3M disclosed across 1 round · 2024
▶$12.3MraisedNov 2024 · 32 investors · BiotechnologyRule 506(b)
▶$12.3MraisedNov 2024 · 32 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Milad AlucozaiDirector
- Brian WilcoveDirector
- Gregory T. TietjenExecutive Officer, Director
- Offering amount
- $17M
- Amount sold
- $12.3M
- First sale
- Oct 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 5
by search overlap
IQVIA16 shared keywordsIQVIA provides data, analytics, AI, and technology-driven services for life sciences and healthcare organizations, spanning clinical development, real world evidence generation, and commercial execution. It offers integrated solutions for clinical trials, regulatory and safety compliance, and market analytics, including agentic AI products for commercial and R&D teams.
Life Biosciences12 shared keywordsLongevity company with diversified therapies to extend healthy human lifespan
Fortis Life Sciences12 shared keywordsFortis Life Sciences develops and manufactures Bethyl-branded ELISA kits and related reagents, buffers, and antibodies for detecting target proteins in research and diagnostic applications. The kits cover human and veterinary targets and are made in the USA using the company's own antibodies.
Ancilia Bio10 shared keywordsAncilia is a biotech company using CRISPR to create beneficial bacterial products, such as live biotherapeutics, that carry immunity against the viruses that destroy them. It develops computational and biological platforms to identify, characterize, and counter viruses within the microbiome (the virome).
Vilya8 shared keywordsVilya designs novel macrocycles using AI and computational biology to create medicines that don't exist in nature. The company develops therapeutics for disease by generating entirely new molecules with the targeting precision of antibodies but in pill form.
Companies competing with Revalia Bio, Inc. for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Revalia Bio, Inc. do?
- Revalia Bio uses AI to convert donated human organs and tissues into multi-modal biological datasets and decision-ready insights for drug and device development. It operates an Organ ICU facility and works with organ procurement organizations and healthcare institutions to serve pharma, biotech, and medical device companies.
- Who founded Revalia Bio, Inc.?
- Revalia Bio, Inc. was founded by Greg Tietjen, Jenna DiRito, Kourosh Saeb-Parsy, Helen Hughes, Peter Buniak, Jenna DiRito, PhD in 2021.
- Who are Revalia Bio, Inc.'s investors?
- Revalia Bio, Inc.'s investors include America's Frontier Fund, Connecticut Innovations, Dnipro, Sierra Ventures, BoxOne Ventures, Entrepreneur First.
- How much funding has Revalia Bio, Inc. raised?
- Revalia Bio, Inc. has disclosed $12.3M raised across 1 round.
- Where is Revalia Bio, Inc. headquartered?
- Revalia Bio, Inc. is headquartered in New Haven, US.